UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
PACIFICHEALTH LABORATORIES, INC
- --------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK, $.0025 PAR VALUE
- --------------------------------------------------------------------------------
(Title of Class of Securities)
695113 10 0
- --------------------------------------------------------------------------------
(CUSIP Number)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
(Continued on the following page(s))
Page 1 of 4 Pages
--- ---
<PAGE>
SCHEDULE 13G
- -------------------------
CUSIP No. 695113 10 0 Page 2 of 4 Pages
- ------------------------- --- ---
- -------------------------------------------------------------------------------
1 | NAMES OF REPORTING PERSON
| S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
|
| Robert Portman, SS# ###-##-####
|
- -------------------------------------------------------------------------------
|
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP: (a) |_|
| (b) |_|
- --------------------------------------------------------------------------------
3 | SEC USE ONLY
|
- --------------------------------------------------------------------------------
4 | CITIZENSHIP OR PLACE OF ORGANIZATION
|
| U.S.A.
- --------------------------------------------------------------------------------
| 5 | SOLE VOTING POWER
| |
| | 1,413,101 shares of Common Stock
NUMBER OF SHARES |-----|--------------------------------------
BENEFICIALLY | 6 | SHARED VOTING POWER
OWNED BY EACH | |
REPORTING PERSON | | None
WITH |-----|--------------------------------------
| 7 | SOLE DISPOSITIVE POWER
| |
| | 1,413,101 shares of Common Stock
|-----|--------------------------------------
| 8 | SHARED DISPOSITIVE POWER
| |
| | None
- --------------------------------------------------------------------------------
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
| 1,413,101 shares of Common Stock, which includes presently-exercisable
| options to acquire 683,334 shares of Common Stock
- --------------------------------------------------------------------------------
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
| SHARES
| |X|
|
| Excludes 200,000 shares of Common Stock owned by reporting person's
| wife, individually and as Trustee for his and her minor children, as
| to which Dr. Portman disclaims beneficial ownership.
- --------------------------------------------------------------------------------
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
| 26.97%
|
- --------------------------------------------------------------------------------
12 | TYPE OF REPORTING PERSON
| IN
|
- --------------------------------------------------------------------------------
<PAGE>
CUSIP No. 695113 10 0 Page 3 of 4 Pages
--- ---
Item 1(a) Name of Issuer: PacificHealth Laboratories, Inc.
Item 1(b) Address of Issuer's Principal Executive Offices:
1480 Route 9 North, Suite 204, Woodbridge, NJ 07095
Item 2(a) Name of Person Filing: Robert Portman
Item 2(b) Address of Principal Business Office or, if none, Residence:
188 Igoe Road, Morganville, NJ 07751
Item 2(c) Citizenship: U.S.A.
Item 2(d) Title of Class of Securities: Common Stock, $.0025 par value
Item 2(e) CUSIP Number: 695113 10 0
Item 3 If this statement is filed pursuant to Rule 13d-1(b) or 13d-2(b):
Not applicable
Item 4 Ownership
(a) Amount Beneficially Owned: 1,413,101 Shares of Common Stock,
which includes presently-exercisable options to acquire 683,334 shares of Common
Stock. Excludes 200,000 shares of Common Stock owned by reporting person's wife,
individually and as Trustee for his and her minor children, as to which Dr.
Portman disclaims beneficial ownership.
(b) Percent of Class: 26.97%
(c) Number of shares as to which such person has:
(i) sole power to vote or direct the vote
1,413,101 Shares
(ii) shared power to vote or direct the vote
0 Shares
(iii) sole power to dispose or to direct the disposition of
1,413,101 Shares
(iv) shared power to dispose or to direct the disposition of
0 Shares
<PAGE>
CUSIP No. 695113 10 0 Page 4 of 4 Pages
--- ---
Item 5 Ownership of Five Percent or Less of a Class
Not applicable
Item 6 Ownership of More than Five Percent on Behalf of Another Person
Not applicable
Item 7 Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company
Not applicable
Item 8 Identification and Classification of Members of a Group
Not applicable
Item 9 Notice of Dissolution of Group
Not applicable
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 11, 1999
------------------------------
(Date)
/s/ Robert Portman
------------------------------
(Signature)
Robert Portman
------------------------------
(Name/Title)
